UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 24, 2005
ADVANCED MAGNETICS, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or other jurisdiction
of incorporation)
|
Commission File No. 0-14732 |
|
04-2742593 |
|
|
|
(IRS Employer |
|
|
|
Identification No.) |
|
|
|
|
|
|
|
|
|
61 Mooney Street |
|
|
|
Cambridge, Massachusetts |
|
02138 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (617) 497-2070
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On March 24, 2005, Advanced Magnetics, Inc. (the “Company”) announced that it received an approvable letter from the U.S. Food and Drug Administration (FDA) regarding Combidex®, the Company’s investigational functional molecular imaging agent. For more information, see the Company’s press release, dated March 24, 2005, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
Exhibit No. Description
99.1 Press release dated March 24, 2005.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
ADVANCED MAGNETICS, INC. |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Jerome Goldstein |
|
||
|
|
|
|
|
|
Name: Jerome Goldstein |
||||
|
|
|
|
|
|
Title: Chief Executive Officer |
||||
EXHIBIT INDEX
Exhibit No. |
|
Description |
99.1 |
|
Press release dated March 24, 2005. |